A fungicide composition of fluopyram and pyraclostrobin

By setting fluopyram as free solid particles, encapsulating pyraclostrobin into microcapsules, and using specific adjuvants to adjust the interface and rheological structure, the particle flocculation and sedimentation problems of fluopyram and pyraclostrobin compound formulations were solved, achieving particle size control and suspension stability.

CN123100609APending Publication Date: 2026-11-17GUANGDONG BINGZHENG CROP TECH CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202611352755.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-02
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing formulations of fluopyram and pyraclostrobin are prone to problems such as particle flocculation, particle size increase, stratification and sedimentation compaction in aqueous suspension systems, and it is difficult to control the particle size and interface state of the two active ingredients separately.

Method used

Fluopyram was set as free solid particles, and pyraclostrobin was encapsulated into microcapsules. Polycarboxylate dispersant, ethylene oxide-propylene oxide block copolymer and protective colloid were used to regulate the interface. Magnesium aluminum silicate and xanthan gum were combined to form a composite rheological structure, and the particle size and sedimentation of the two components were controlled respectively.

Benefits of technology

This technology enables the separate control of the particle size of fluopyram particles and pyraclostrobin microcapsules in an aqueous continuous phase, reducing flocculation and sedimentation, maintaining the suspension state and operational fluidity of the formulation, and improving dilution stability and redispersibility.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_5
    Figure SMS_5
Patent Text Reader

Abstract

This invention provides a fungicide composition of fluopyram and pyraclostrobin, comprising an aqueous continuous phase and fluopyram particles and pyraclostrobin microcapsules dispersed in the aqueous continuous phase. The composition is characterized in that, based on the total mass of the fungicide composition, the content of fluopyram is 10%–20%, and the content of pyraclostrobin is 10%–20%; the fluopyram exists in the aqueous continuous phase as free solid particles. This invention sets fluopyram as free solid particles and sets pyraclostrobin within microcapsules having an oil core and a polymer wall, allowing the two active ingredients to exist in different dispersed phases. This enables separate control of the particle size of the fluopyram particles and the pyraclostrobin microcapsules, reducing competitive adsorption and heterogeneous particle aggregation that occur when different active ingredient particles are co-ground.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of pesticide formulation technology, and in particular to a fungicide composition of fluopyram and pyraclostrobin. Background Technology

[0002] Both fluopyram and pyraclostrobin can be used as fungicidal active ingredients for the control of fungal diseases in crops. In order to balance the control range and resistance management, the two have been combined in existing technologies and formulated into suspensions, dispersible oil suspensions, water emulsions, microemulsions, water-dispersible granules or emulsifiable concentrates.

[0003] For example, CN107006480A discloses a compound combination of fluopyram and pyraclostrobin, in which the weight ratio of the two active ingredients can be 1:40 to 40:1, and describes formulations such as suspension concentrate, dispersible oil suspension concentrate, water emulsion, microemulsion, water-dispersible granules or emulsifiable concentrate; CN107494568A also discloses the compound of fluopyram and pyraclostrobin and its application in the control of diseases in tomatoes and pears.

[0004] In conventional aqueous suspension formulations, two active ingredients are usually added to the aqueous phase along with dispersants, wetting agents, and thickeners. After pre-dispersion and wet milling, a mixed suspension system is formed. Due to the differences in the crystal properties, particle size variations, and interfacial adsorption states of the two active ingredients, competitive adsorption by the dispersant is likely to occur after co-milling. When the content of active ingredients is high or when the system experiences temperature changes or long-term standing, particle flocculation, particle size increase, stratification, and sedimentation compaction may also occur.

[0005] To mitigate sedimentation, existing formulations typically increase the amount of dispersant or thickener. However, increasing the amount of dispersant may cause changes in foaming and dilution stability, while excessive thickener usage will increase the viscosity of the formulation, affecting pouring, pumping, and spraying. Simply adjusting the adjuvant content makes it difficult to separately control the particle size, morphology, and interfacial state of fluopyram and pyraclostrobin in aqueous systems.

[0006] Therefore, a fungicide composition of fluopyram and pyraclostrobin is proposed. Summary of the Invention

[0007] The technical solution of the present invention is implemented as follows: a fungicide composition of fluopyram and pyraclostrobin, comprising an aqueous continuous phase and fluopyram particles and pyraclostrobin microcapsules dispersed in the aqueous continuous phase.

[0008] The content of fluopyram is 10%–20% and the content of pyraclostrobin is 10%–20% based on the total mass of the bactericidal composition.

[0009] Fluopyram exists in the form of free solid particles in an aqueous continuous phase; pyraclostrobin microcapsules include an oil core and a polymer capsule wall covering the oil core. Pyraclostrobin is dissolved in the oil phase carrier to form the oil core. The two active ingredients exist in different physical forms, so that the grinding particle size of fluopyram particles and the particle size of pyraclostrobin microcapsules can be controlled separately.

[0010] The aqueous continuous phase contains a polycarboxylate dispersant, an ethylene oxide-propylene oxide block copolymer, a protective colloid, and a composite rheology modifier, wherein the composite rheology modifier is composed of magnesium aluminum silicate and xanthan gum.

[0011] Polycarboxylate dispersants and ethylene oxide-propylene oxide block copolymers are distributed at the interface between fluopyram particles and pyraclostrobin microcapsules, reducing direct contact between the two dispersed phases in the aqueous continuous phase; protective colloids are used to maintain the interfacial state of pyraclostrobin microcapsules; magnesium aluminum silicate and xanthan gum form a composite rheological structure in the aqueous continuous phase to limit the migration and sedimentation of fluopyram particles and pyraclostrobin microcapsules during the standing process.

[0012] More preferably, the mass percentage combination of fluopyram and pyraclostrobin is 10% and 20%, 15% and 15%, or 20% and 10%.

[0013] The D50 of the fluopyram particles is 0.6 μm to 1.5 μm, the D90 is 2.0 μm to 4.0 μm, and the D100 is not greater than 8 μm; the D50 of the pyraclostrobin microcapsules is 2 μm to 6 μm, and the D90 is not greater than 10 μm.

[0014] The oil phase carrier is selected from C8-C10 fatty acid methyl esters, lactic acid-2-ethylhexyl esters, and mixtures of C8-C10 fatty acid methyl esters and lactic acid-2-ethylhexyl esters. The oil phase carrier is used to dissolve pyraclostrobin and serves as the oil core of the microcapsules.

[0015] The polymer capsule wall is a polyurea capsule wall, which is formed by the reaction of polymethylene polyphenyl isocyanate and diethylenetriamine. The mass ratio of the polymer capsule wall to the oil core is 1:12 to 1:30.

[0016] The protective colloid is polyvinyl alcohol, and the mass ratio of the polycarboxylate dispersant to the ethylene oxide-propylene oxide block copolymer is 1:0.3 to 1:1.2; the pH value of the bactericidal composition is 6.2 to 7.2, and within this pH range, the zeta potential of both fluopyram particles and pyraclostrobin microcapsules is -20mV to -45mV.

[0017] The content of magnesium aluminum silicate is 0.3% to 0.8% and the content of xanthan gum is 0.08% to 0.25% based on the total mass of the bactericidal composition. The mass ratio of magnesium aluminum silicate to xanthan gum is 2:1 to 6:1.

[0018] Based on the total mass of the bactericidal composition, it includes:

[0019] The composition comprises: 10%–20% fluopyram, 10%–20% pyraclostrobin, 8%–22% oil phase carrier, 0.5%–2.5% polymer capsule wall material, 1.0%–3.5% polycarboxylate dispersant, 0.8%–3.0% ethylene oxide-propylene oxide block copolymer and protective colloid, 3%–8% antifreeze, 0.2%–1.2% composite rheology modifier, 0.05%–0.30% defoamer, 0.05%–0.20% preservative, 0.05%–0.50% pH adjuster, and the balance being water. The sum of the mass percentages of all components is 100%.

[0020] The antifreeze is used to reduce the possibility of the aqueous continuous phase freezing or viscosity abruptly changing under low temperature conditions; the defoamer is used to control foaming during preparation and use; the preservative is used to inhibit the growth of microorganisms during storage of the aqueous preparation; and the pH adjuster is used to maintain the acidity or alkalinity of the aqueous continuous phase.

[0021] The embodiments of the present invention have the following advantages due to the adoption of the above technical solutions:

[0022] I. In this invention, fluopyram is set as free solid particles, and pyraclostrobin is set in microcapsules with an oil core and a polymer capsule wall, so that the two active ingredients exist in different dispersed phases. The particle size of fluopyram particles and pyraclostrobin microcapsules can be controlled separately, reducing competitive adsorption and heterogeneous particle aggregation caused by grinding different active ingredients together.

[0023] Second, the polycarboxylate dispersant, ethylene oxide-propylene oxide block copolymer and protective colloid of the present invention work together at the interface of the two types of dispersed phases to keep the fluopyram particles and pyraclostrobin microcapsules separated in the aqueous continuous phase, reducing the possibility of flocs forming after the two types of dispersed phases come into direct contact.

[0024] Third, the composite rheological structure formed by magnesium aluminum silicate and xanthan gum in this invention can restrict the sedimentation of particles and microcapsules in a static state, and can recover flow under shearing during stirring, pouring or spraying, thereby taking into account the suspension state, redispersibility and handling flowability of the formulation. Detailed Implementation

[0025] This invention provides a fungicide composition of fluopyram and pyraclostrobin. The composition is an aqueous composite dispersion system. Fluopyram is dispersed in the aqueous continuous phase as free solid particles. Pyraclostrobin is dissolved in the oil phase carrier and then encapsulated by the polymer capsule wall to form pyraclostrobin microcapsules. The two active ingredients are not ground together as solid particles, but are respectively formed as fluopyram particle dispersion phase and pyraclostrobin microcapsule dispersion phase, and then compounded in the same aqueous continuous phase.

[0026] In this embodiment, D50, D90, and D100 of fluopyram particles represent the particle size corresponding to a cumulative particle size distribution of 50%, 90%, and 100%, respectively; D50 and D90 of pyraclostrobin microcapsules have the same meaning.

[0027] Example 1

[0028] This embodiment provides a bactericidal composition with a fluopyram content of 10% and a pyraclostrobin content of 20%, and the components are shown in the table below.

[0029] Table 1. Component composition of Example 1 Components mass percentage content / % Fluopyram 10.00 Pyraclostrobin 20.00 C8-C10 fatty acid methyl esters 12.00 2-Ethylhexyl lactate 6.00 Polymethylene polyphenyl isocyanate 1.10 Diethylenetriamine 0.30 polycarboxylate dispersants 1.50 ethylene oxide-propylene oxide block copolymer 1.00 Polyvinyl alcohol 0.60 Propylene glycol 4.00 Magnesium aluminum silicate 0.60 Xanthan Gum 0.18 silicone defoamer 0.15 preservative 0.10 Citric acid-sodium citrate buffer 0.20 Deionized water 42.27 total 100.00

[0030] The bactericidal composition of this embodiment is prepared according to the following process:

[0031] C8-C10 fatty acid methyl esters and lactic acid-2-ethylhexyl esters were added to an oil phase preparation container, and the temperature was raised to 40°C while stirring. Pyraclostrobin was added, and the stirring speed was controlled at 450 r / min. After the pyraclostrobin was dissolved, polymethylene polyphenyl isocyanate was added, and stirring was continued for 15 min to obtain the pyraclostrobin oil phase.

[0032] Take a portion of the deionized water from the formulation, add polyvinyl alcohol, a portion of ethylene oxide-propylene oxide block copolymer, and a portion of polycarboxylate dispersant, and stir until all additives are evenly dispersed to form the aqueous phase for microcapsule preparation. The amount of polycarboxylate dispersant added to this aqueous phase accounts for 30% to 50% of its total amount, and the remainder is used for the fluopyram grinding slurry.

[0033] The pyraclostrobin oil phase was slowly added to the aqueous phase for microcapsule preparation, and sheared and emulsified at 8000 r / min for 10 min to form an oil-in-water emulsion. Diethylenetriamine was prepared into a 10% (w / w) aqueous solution, and the water used was included in the total amount of deionized water in the formulation. The diethylenetriamine aqueous solution was slowly added to the oil-in-water emulsion, and the reaction was carried out at 25℃ and 450 r / min for 45 min. Subsequently, the temperature was raised to 45℃ and maintained for 1.5 h, allowing polymethylene polyphenyl isocyanate to react with diethylenetriamine at the oil-water interface to form a polyurea capsule wall, thus obtaining a pyraclostrobin microcapsule suspension.

[0034] During the microcapsule formation process, the oil droplet size is controlled by shear rate and emulsification time, so that the D50 of the obtained pyraclostrobin microcapsules is between 2μm and 6μm, and the D90 is not greater than 10μm. In this embodiment, the mass ratio of the polymer capsule wall material to the oil core composed of pyraclostrobin and oil phase carrier is about 1:27.

[0035] Take another portion of deionized water, add propylene glycol, the remaining polycarboxylate dispersant and ethylene oxide-propylene oxide block copolymer, and stir at 1000 r / min until uniformly mixed; add fluopyram technical and pre-disperse at 2000 r / min for 20 min to obtain fluopyram pre-dispersed slurry.

[0036] The pre-dispersed slurry was fed into a sand mill and wet-milled using zirconia beads with a particle size of 0.5 mm to 0.8 mm. During the milling process, the slurry temperature was controlled below 35°C using a circulating cooling method. The slurry was milled until the D50 of the fluopyram particles was 0.6 μm to 1.5 μm, the D90 was 2.0 μm to 4.0 μm, and the D100 was not greater than 8 μm, thus obtaining the fluopyram milling slurry.

[0037] Magnesium aluminum silicate was slowly added to another portion of deionized water, stirred at 800 r / min and hydrated for 45 min; after reducing the speed, xanthan gum was added in batches, and stirring was continued for 30 min to allow the xanthan gum to fully expand and form a uniform composite rheological pregel with magnesium aluminum silicate.

[0038] Place the fluopyram slurry in a compounding container and stir at 400 r / min. Slowly add the pyraclostrobin microcapsule suspension. After the two phases are mixed evenly, add the composite rheology pregel, then add the organosilicon defoamer, preservative and citric acid-sodium citrate buffer, and add the remaining deionized water to adjust the pH of the system to 6.2-7.2.

[0039] In the compounding stage, no sand milling or high-speed homogenization is performed to reduce the damage to the polyurea capsule wall under high shear. After the materials are mixed evenly, they are filtered through a 120μm pore size filter to obtain the fungicidal composition of fluopyram and pyraclostrobin in this embodiment.

[0040] Example 2

[0041] This embodiment provides a bactericidal composition in which both fluopyram and pyraclostrobin have a mass percentage of 15%, and the components are shown in the table below.

[0042] Table 2 Component composition of Example 2 Components mass percentage content / % Fluopyram 15.00 Pyraclostrobin 15.00 C8-C10 fatty acid methyl esters 10.00 2-Ethylhexyl lactate 5.00 Polymethylene polyphenyl isocyanate 0.80 Diethylenetriamine 0.25 polycarboxylate dispersants 1.50 ethylene oxide-propylene oxide block copolymer 1.00 Polyvinyl alcohol 0.60 Propylene glycol 4.00 Magnesium aluminum silicate 0.60 Xanthan Gum 0.18 silicone defoamer 0.15 preservative 0.10 Citric acid-sodium citrate buffer 0.20 Deionized water 45.62 total 100.00

[0043] The preparation process of this embodiment is basically the same as that of Example 1; pyraclostrobin is added to an oil phase carrier composed of C8-C10 fatty acid methyl ester and lactic acid-2-ethylhexyl ester and dissolved at 40°C; pyraclostrobin microcapsules are formed by shear emulsification and interfacial polymerization, and the mass ratio of polymer capsule wall material to oil core is about 1:29.

[0044] Fluopyram was pre-dispersed and wet-milled to form a fluopyram slurry; magnesium aluminum silicate and xanthan gum were hydrated and expanded in water to form a composite rheology pregel; the pyraclostrobin microcapsule suspension, fluopyram slurry and composite rheology pregel were mixed sequentially, the pH was adjusted to 6.2-7.2, water was added and the mixture was filtered to obtain the bactericidal composition of this embodiment.

[0045] In this embodiment, the mass ratio of the two active ingredients is 1:1. Fluopyram exists in the form of free solid particles, while pyraclostrobin is located in the oil core encapsulated by the polyurea capsule wall. The two types of dispersed phases are distributed together in the aqueous continuous phase.

[0046] Example 3

[0047] This embodiment provides a bactericidal composition with a fluopyram content of 20% and a pyraclostrobin content of 10%, and the components are shown in the table below.

[0048] Table 3. Component composition of Example 3 Components mass percentage content / % Fluopyram 20.00 Pyraclostrobin 10.00 C8-C10 fatty acid methyl esters 8.00 2-Ethylhexyl lactate 4.00 Polymethylene polyphenyl isocyanate 0.70 Diethylenetriamine 0.20 polycarboxylate dispersants 1.50 ethylene oxide-propylene oxide block copolymer 1.00 Polyvinyl alcohol 0.60 Propylene glycol 4.00 Magnesium aluminum silicate 0.60 Xanthan Gum 0.18 silicone defoamer 0.15 preservative 0.10 Citric acid-sodium citrate buffer 0.20 Deionized water 48.77 total 100.00

[0049] In this embodiment, pyraclostrobin microcapsule suspension, fluopyram grinding slurry, and composite rheology pregel were prepared in the order described in Example 1. In the pyraclostrobin microcapsules, the mass ratio of polymer capsule wall material to oil core was approximately 1:24.

[0050] As the content of fluopyram increases, the concentration of solid particles in the grinding slurry increases accordingly. During pre-dispersion, the polycarboxylate dispersant and ethylene oxide-propylene oxide block copolymer are added to the aqueous phase first. After the additives are evenly dispersed, fluopyram is added in batches to avoid the formation of clumps that are difficult to disperse after the active ingredient is added all at once.

[0051] During the sand milling process, the slurry temperature is controlled below 35°C, and the particle size detection result is used as the grinding endpoint. After the specified particle size is reached, the pyraclostrobin microcapsule suspension is added to the fluopyram grinding slurry at 400 r / min. Then, the composite rheology pregel and other adjuvants are added, the pH is adjusted and water is added, and the bactericidal composition of this embodiment is obtained after filtration.

[0052] Comparative Example 1

[0053] The dosages of fluopyram, pyraclostrobin, and adjuvants in this comparative example are the same as in Example 2. The difference is that pyraclostrobin is not dissolved in the oil phase and microencapsulated. Instead, fluopyram and pyraclostrobin are added to the aqueous phase simultaneously for pre-dispersion and wet grinding.

[0054] Polycarboxylate dispersant, ethylene oxide-propylene oxide block copolymer, polyvinyl alcohol and propylene glycol were added to water and mixed evenly. Fluopyram and pyraclostrobin were then added and pre-dispersed at 2000 r / min for 20 min. The mixture was then sand-milled using zirconia beads. After grinding, a composite rheology pregel formed by magnesium aluminum silicate and xanthan gum, defoamer, preservative and buffer were added, and water was added to 100%.

[0055] In this comparative example, both active ingredients exist in the form of free solid particles, and are used for comparison with the particle-microcapsule phase separation system of Example 2.

[0056] Comparative Example 2

[0057] The active ingredient content, microcapsule structure, and other additive composition of this comparative example are the same as those of Example 2, except that only xanthan gum is used as the rheology modifier, and magnesium aluminum silicate is not added.

[0058] In Comparative Example 2, the amount of xanthan gum added was set according to the amount of xanthan gum used in Example 2, and the other preparation conditions remained the same. This was used to compare the differences between the single xanthan gum system and the magnesium aluminum silicate-xanthan gum composite rheological system in terms of standing, pouring and redispersibility.

[0059] Comparative Example 3

[0060] The effective ingredient content, pyraclostrobin microcapsule structure, and composite rheology modifier composition of this comparative example are the same as those of Example 2. The difference is that the polycarboxylate dispersant is added entirely to the fluopyram grinding slurry, and the polycarboxylate dispersant is not added to the aqueous phase for the preparation of pyraclostrobin microcapsules.

[0061] This comparative example is used to compare the system states when the polycarboxylate dispersant acts only on fluopyram particles and when the polycarboxylate dispersant participates in the interface regulation of two types of dispersed phases respectively.

[0062] Test Example 1

[0063] Samples prepared in Examples 1-3 and Comparative Examples 1-3 were tested respectively.

[0064] Before compounding, samples of fluopyram grinding slurry and pyraclostrobin microcapsule suspension were taken separately and their particle size was determined using a laser particle size analyzer. During testing, the microcapsule suspension was diluted with deionized water to the light-shielding range specified by the instrument. The microcapsule suspension was treated with a low-shear dispersion method to avoid damaging the polymer capsule wall during the dispersion operation before testing.

[0065] The zeta potential was determined by electrophoretic light scattering. The sample was diluted with deionized water at pH 6.8 and detected at 25°C.

[0066] The encapsulation efficiency of pyraclostrobin is calculated by determining the free pyraclostrobin content and the total pyraclostrobin content, as shown in the following formula:

[0067]

[0068] In the formula, The encapsulation rate of pyraclostrobin; This represents the total mass of pyraclostrobin in the sample; The quality of free pyraclostrobin outside the microcapsules; the test results are shown in Table 4.

[0069] Table 4. Particle size, encapsulation efficiency, and zeta potential of each sample sample Fluopyram D50 / μm Fluopyram D90 / μm Fluopyram D100 / μm Microcapsule D50 / μm Microcapsule D90 / μm Encapsulation rate / % Fluopyram zeta potential / mV Microcapsule ζ-potential / mV Example 1 1.08 2.86 6.70 4.20 8.70 90.7 -31.8 -29.6 Example 2 0.95 2.62 6.30 3.80 8.10 92.1 -34.2 -32.6 Example 3 1.22 3.18 7.20 3.50 7.80 91.4 -28.7 -30.1 Comparative Example 1 1.35 3.55 8.90 — — — -21.4 — Comparative Example 2 0.98 2.70 6.50 3.90 8.30 91.8 -33.5 -31.9 Comparative Example 3 1.04 2.78 6.60 4.10 8.80 89.5 -32.8 -18.6

[0070] As shown in Table 4, the D90 of fluopyram particles in Examples 1-3 were all between 2.0 μm and 4.0 μm, while the D90 of pyraclostrobin microcapsules did not exceed 10 μm, and the encapsulation efficiency of pyraclostrobin was higher than 90%. The zeta potentials of both types of dispersed phases were negative and their absolute values ​​were close, indicating that they have similar interfacial electrical properties in the aqueous continuous phase.

[0071] Comparative Example 1 used two active ingredients for co-grinding, and no pyraclostrobin microcapsules were found; the solid particle size (D100) of Comparative Example 3 did not add polycarboxylate dispersant to the aqueous phase for microcapsule preparation, and the absolute value of the zeta potential of the microcapsules decreased, indicating that the surface interface state of the microcapsules changed.

[0072] Test Example 2

[0073] Take 500g each of Examples 1-3 and Comparative Examples 1-3, and dispense them into sealed containers. The heat storage test was conducted at 54℃±2℃ for 14 days, and the low-temperature test was conducted at 0℃±2℃ for 7 days. After the tests, the samples were restored to 25℃, and the stratification, flocculation, crystallization, and bottom deposition states were observed. The suspension rate and particle size changes were also measured.

[0074] Suspension rate was determined by preparing suspensions using the same mass of sample and standard hard water, and measuring the content of active ingredients in the upper suspension after standing for a specified time. Redispersibility was expressed as the number of container inversions required for the deposited sample to regain homogeneity.

[0075] The test results after heat storage are shown in Table 5.

[0076] Table 5. Stability of each sample after thermal storage sample D90 / μm before heat storage D90 / μm after heat storage D90 change rate / % Suspension rate after heat storage / % Number of re-dispersed flips / times Appearance Example 1 2.86 3.11 8.7 96.1 4 No obvious stratification, with a small amount of loose sediment at the bottom. Example 2 2.62 2.80 6.9 97.0 3 The system was homogeneous and no obvious crystallization was observed. Example 3 3.18 3.48 9.4 95.5 5 No obvious stratification; sediments can be redispersed. Comparative Example 1 3.55 5.82 63.9 86.7 18 Layered and bottom compacted sediments were observed. Comparative Example 2 2.70 3.39 25.6 90.2 13 The upper part has slight stratification, while the bottom has more obvious deposition. Comparative Example 3 2.78 3.74 34.5 89.4 15 Flocculation occurs, and the mixture separates into layers after standing.

[0077] D90 in the table represents the test results for fluopyram particles.

[0078] In Examples 1-3, the D90 change rate after heat storage was less than 10%, the suspension rate remained above 95%, and the bottom sediment could be redispersed after 3-5 flips. In Comparative Example 1, the two active ingredients were ground together, and the D90 of the particles increased significantly after heat storage, forming a denser bottom sediment.

[0079] Comparative Example 2, without the addition of magnesium aluminum silicate, only used xanthan gum to adjust the rheological state. Significant sedimentation occurred after standing, indicating that the aqueous phase structure formed by xanthan gum alone was insufficient to confine the two dispersed phases. In Comparative Example 3, the difference between the interfacial potential of the microcapsules and the fluopyram particles increased, and flocculation and stratification occurred after heat storage.

[0080] After being placed at 0°C for 7 days, no obvious crystallization or irreversible agglomeration was observed in Examples 1-3. After being restored to 25°C and slightly turned over, the samples were able to reform a uniformly dispersed system. Local flocculent aggregates appeared in Comparative Examples 1 and 3.

[0081] Test Example 3

[0082] Examples 1-3 and Comparative Examples 1-3 were placed into 500mL test containers and allowed to stand at 25°C for 30 days. After standing, the containers were inverted for 60 seconds, the mass of the residual sample in the containers was weighed, and the decanting residue rate was calculated.

[0083] The residual dumping rate is calculated using the following formula:

[0084]

[0085] In the formula, The residual rate after dumping; The mass of the sample remaining in the container after pouring; This refers to the mass of the sample in the container before it is poured out.

[0086] After pouring, add deionized water equivalent to 10% of the original sample mass to the container, invert it 5 times, pour it out again, and observe the residue at the bottom of the container. The test results are shown in Table 6.

[0087] Table 6. Pourability and redispersibility of each sample sample First dumping residual rate / % Residual rate after cleaning / % Bottom sedimentation state redistribution Example 1 3.1 0.8 Small amount of loose sediment Disperse evenly after flipping. Example 2 2.6 0.6 No compacted layer formed Disperse evenly after flipping. Example 3 3.8 1.0 Small amount of sediment No obvious residue after flipping Comparative Example 1 8.9 4.7 Formation of compacted sedimentary layer Blocky residue remained after flipping. Comparative Example 2 6.5 3.1 Thick sedimentary layer It can be dispersed, but requires a large number of flips. Comparative Example 3 7.2 3.8 Flocculents adhere to the bottom of the container Even after turning, there are still flocculent residues.

[0088] The initial pouring residual rates of Examples 1-3 were all less than 4%, and the residual rates after adding water and turning over did not exceed 1%. The composite rheological system formed by magnesium aluminum silicate and xanthan gum restricts particles and microcapsules when stationary, and the system can flow under shear after the container is inverted, without forming a bottom compaction layer that is difficult to remove.

[0089] Comparative Example 1 used a co-grinding system, which resulted in particle aggregation and compaction after prolonged standing. Comparative Example 2 used only xanthan gum, which increased the viscosity of the system, but the settled particles still tended to concentrate at the bottom of the container. Comparative Example 3 showed the presence of flocculent adhesion.

[0090] Test Example 4

[0091] Take 1.0 g each of Examples 1-3 and Comparative Examples 1-3, add them to standard hard water, and prepare 100-fold and 500-fold dilutions respectively. After stirring the dilutions at 200 r / min for 2 min, transfer them to a graduated cylinder and let them stand at 25°C for 2 h to observe whether flocculation, precipitation, floating oil, and obvious stratification occur.

[0092] The test results are shown in Table 7.

[0093] Table 7 Dilution stability of each sample sample 100x dilution 500x dilution Settling state after standing for 2 hours Example 1 Evenly dispersed, with no floating oil. Evenly dispersed, with no obvious flocculation. No obvious sediment at the bottom Example 2 Evenly dispersed, with no floating oil. Evenly dispersed, with no obvious flocculation. No obvious sediment at the bottom Example 3 Evenly dispersed, with no floating oil. Slightly milky white, no flocculation observed. A small amount of loose sediment at the bottom Comparative Example 1 A small amount of coarse particles appeared Flocculent material appears Obvious sedimentation formed at the bottom Comparative Example 2 The dispersion is basically uniform Settling occurred after standing. The bottom sedimentation is more obvious Comparative Example 3 Slight flocculation occurred Increased flocculent matter Uneven condition between upper and lower layers

[0094] No obvious floating oil or flocculation was observed in Examples 1-3 under 100-fold and 500-fold dilution conditions, and the two types of dispersed phases were able to maintain dispersion after dilution with water;

[0095] In Comparative Example 1, both active ingredients existed as co-ground solid particles, and after dilution, coarse particles and flocculent matter were visible.

[0096] In Comparative Example 3, due to insufficient stability of the microcapsule interface, aggregation occurred between the microcapsules and fluopyram particles after dilution.

[0097] The test results above indicate that in Examples 1-3, the phase separation of fluopyram solid particles and pyraclostrobin microcapsules allows for separate control of the particle size of the two dispersed phases. The polycarboxylate dispersant, ethylene oxide-propylene oxide block copolymer, and polyvinyl alcohol work together to regulate the interfacial state of the particles and microcapsules, ensuring that they maintain the same electrical orientation in the aqueous continuous phase.

[0098] The composite rheological structure formed by magnesium aluminum silicate and xanthan gum restricts particle migration and sedimentation under static conditions without compromising the formulation's pouring and redispersibility. Compared to comparative examples with co-milling, single xanthan gum, and insufficient microcapsule interface stability, the formulations in this example are more stable in terms of particle size, suspension, and redispersibility after heat storage, low temperature, long-term static storage, and dilution with water.

[0099] The above description is merely a specific embodiment of the present invention, but the scope of protection of the present invention is not limited thereto. Any person skilled in the art can easily conceive of various variations or substitutions within the technical scope disclosed in the present invention, and these should all be included within the scope of protection of the present invention. Therefore, the scope of protection of the present invention should be determined by the scope of the claims.

Claims

1. A fungicidal composition of fluoxastrobin and pyraclostrobin comprising an aqueous continuous phase and particles of fluoxastrobin and microcapsules of pyraclostrobin dispersed in the aqueous continuous phase, characterized in that, Based on the total mass of the bactericidal composition, the content of fluopyram is 10% to 20%, and the content of pyraclostrobin is 10% to 20%. The fluopyram exists in the aqueous continuous phase in the form of free solid particles, and the pyraclostrobin microcapsules include an oil core formed by an oil phase carrier and a polymer capsule wall covering the oil core, wherein the pyraclostrobin is dissolved in the oil core. The aqueous continuous phase contains a polycarboxylate dispersant, an ethylene oxide-propylene oxide block copolymer, a protective colloid, and a composite rheology modifier, wherein the composite rheology modifier is composed of magnesium aluminum silicate and xanthan gum.

2. The fungicidal combination of fluazinam and pyraclostrobin according to claim 1, characterized in that, The mass percentage combination of fluopyram and pyraclostrobin is one of 10% and 20%, 15% and 15%, or 20% and 10%.

3. The fungicidal combination of fluazinam and pyraclostrobin according to claim 1, characterized in that, The D50 of the fluopyram particles is 0.6 μm to 1.5 μm, the D90 is 2.0 μm to 4.0 μm, and the D100 is not greater than 8 μm; the D50 of the pyraclostrobin microcapsules is 2 μm to 6 μm, and the D90 is not greater than 10 μm.

4. The fungicidal combination of fluazinam and pyraclostrobin according to claim 1, characterized in that, The oil phase carrier is selected from C8-C10 fatty acid methyl esters, 2-ethylhexyl lactate, and mixtures of C8-C10 fatty acid methyl esters and 2-ethylhexyl lactate; the polymer capsule wall is a polyurea capsule wall, which is formed by reacting polymethylene polyphenyl isocyanate with diethylenetriamine.

5. The fungicidal combination of fluazinam and pyraclostrobin according to claim 1, characterized in that, The protective colloid is polyvinyl alcohol, and the mass ratio of the polycarboxylate dispersant to the ethylene oxide-propylene oxide block copolymer is 1:0.3 to 1:1.2; when the pH value of the bactericidal composition is 6.2 to 7.2, the zeta potential of the fluopyram particles and the pyraclostrobin microcapsules is -20mV to -45mV.

6. The fungicidal combination of fluazinam and pyraclostrobin according to claim 1, characterized in that, Based on the total mass of the bactericidal composition, the content of magnesium aluminum silicate is 0.3% to 0.8%, the content of xanthan gum is 0.08% to 0.25%, and the mass ratio of magnesium aluminum silicate to xanthan gum is 2:1 to 6:

1.

7. The fungicidal combination of fluazinam and pyraclostrobin according to claim 1, characterized in that, The bactericidal composition comprises, by total mass, 10%–20% fluopyram, 10%–20% pyraclostrobin, 8%–22% oil phase carrier, 0.5%–2.5% polymer capsule wall material, 1.0%–3.5% polycarboxylate dispersant, 0.8%–3.0% ethylene oxide-propylene oxide block copolymer and protective colloid, 3%–8% antifreeze, 0.2%–1.2% composite rheology modifier, 0.05%–0.30% defoamer, 0.05%–0.20% preservative, 0.05%–0.50% pH adjuster, and the balance being water, wherein the sum of the mass percentages of all components is 100%.

8. The fungicidal combination of fluazinam and pyraclostrobin according to claim 4, characterized in that, The mass ratio of the polymer capsule wall to the oil core is 1:12 to 1:30, and the pH value of the bactericidal composition is 6.2 to 7.2.

Citation Information

Patent Citations

  • Bactericidal composition containing fluorazolamide

    CN107006480A

  • Compound synergistic bactericidal composition for preventing and curing main diseases of tomatoes and pear trees, and application of composition

    CN107494568A